CrossBridge is developing the most comprehensive, specialty decision-making Software as a Service (SaaS) solution available today for improving outcomes and lowering the cost of treating chronic inflammatory diseases.
Aligns the priorities of providers and payers, and simplifies administration, so patients can begin receiving treatment without delay. Pre-auths are instantaneous for treatment plans submitted per the CrossBridge Evidence-based Treatment Library (EBML) of nationally accepted standards of care.
Providers can submit research from our library to justify deviations from standards.
Payers can accept or deny payment per treatment plan through the CrossBridge technology platform, where providers can track plan progress.
The library is the heart of the CrossBridge solution. Independent and non-biased, it is based on medical society guidelines as a starting point and augmented with the latest validated research.
There are comprehensive treatment plans for chronic autoimmune diseases, accompanied by clinical outcomes and levels of medical evidence per specialty.
From treatment plan selection through reimbursement, the CrossBridge approach is fully aligned with the goal of the Centers for Medicare & Medicaid Services (CMS) and payers – to transition from fee-for-service payment to Alternative Payment Models (APMs)…Value-Based Care (VBC).
VBC demands collaboration between payers and providers to analyze patient/member populations and make shared patient-provider treatment decisions based on actionable data.
The CrossBridge solution make this possible like never before with chronic inflammatory diseases.